Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
Richard D Riley(University of Birmingham), Jill A. Hayden(Dalhousie University), Ewout W. Steyerberg(Erasmus MC), Karel G.M. Moons(University Medical Center Utrecht), Keith R. Abrams(University of Leicester), P. Kyzas(North Manchester General Hospital), Núria Malats(Spanish National Cancer Research Centre), Andrew Briggs(University of Glasgow), Sara Schroter, Douglas G. Altman(University of Oxford), Harry Hemingway(University College London), for the PROGRESS Group
Cited by 809Open Access
Abstract
Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.
Related Papers
No related papers found
Powered by citation graph analysis